Please use this identifier to cite or link to this item: http://hdl.handle.net/2445/176621
Title: The Diagnostic Value of Onconeural Antibodies Depends on How They Are Tested
Author: Ruíz García, Raquel
Martínez Hernández, Eugenia
Saiz Hinajeros, Albert
Dalmau Obrador, Josep
Graus Ribas, Francesc
Keywords: Anticossos monoclonals
Diagnòstic
Monoclonal antibodies
Diagnosis
Issue Date: 14-Jul-2020
Publisher: Frontiers Media
Abstract: Detection of onconeural antibodies is important because establishes a definitive diagnosis of paraneoplastic neurological syndrome (PNS). The recommended method for diagnosis of onconeural antibodies is by immunohistochemistry on rodent brain sections and confirmation of results by immunoblot. However, in many diagnostic laboratories samples are only tested with commercial line blots. In this study we inquired whether this change in diagnostic methodology (line blot alone vs. combined immunohistochemistry and line blot) would affect the results. Among 439 samples examined by immunohistochemistry and a commercial line blot (Euroimmun, Lübeck, Germany) 96 (22%) were positive by line blot, and their clinical information was reviewed. Onconeural antibodies were detected by both assays in 46/96 (48%) patients (concordant group) whereas 50 (52%) were only positive by line blot (discordant group). In the concordant group 42/46 (91%) patients had a definite diagnosis of PNS whereas in the discordant group only 4/50 (8%) had PNS (p < 0.00001). None of the 14 patients with ZIC4 antibodies and 1/13 (8%) with Yo antibodies demonstrated only by line blot had PNS. These findings show a robust diagnostic value of combined diagnostic techniques, and both should be used to demonstrate onconeural antibodies, If antibody testing is performed only with line blot assay, positive bands should be confirmed by rodent brain immunohistochemistry. For ZIC4 or Yo antibody testing, line blot positivity with negative immunohistochemistry has no diagnostic significance, and for the rest of onconeural antibodies the predictive diagnostic value is low.
Note: Reproducció del document publicat a: https://doi.org/10.3389/fimmu.2020.01482
It is part of: Frontiers in Immunology, 2020, vol. 11, p. 1482
URI: http://hdl.handle.net/2445/176621
Related resource: https://doi.org/10.3389/fimmu.2020.01482
ISSN: 1664-3224
Appears in Collections:Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer)
Articles publicats en revistes (Medicina)

Files in This Item:
File Description SizeFormat 
709121.pdf613.95 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons